Thyroid Ablation Devices Market Size & Growth Forecast 2026–2035, By Segments (Product, Application, End-use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Thyroid Ablation Devices Market size was over USD 196.68 Million in 2025 and is likely to grow at a 9.7% CAGR between 2026 and 2035, reaching USD 496.39 Million by 2035. The industry revenue for 2026 is estimated at USD 213.32 million.
Get more details on this report
Request Free Sample ReportThyroid Ablation Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 37.42% share in 2025, supported by established image-guided treatment pathways, broad specialist expertise, and strong adoption of minimally invasive thyroid procedures.
- Asia Pacific is projected to expand at a 10.96% CAGR as healthcare infrastructure improves, ultrasound-guided procedures gain wider adoption, and demand rises for minimally invasive thyroid treatments.
Segment Momentum
- Thermal Based Devices accounted for 67.9% of the market in 2025 due to established procedural familiarity, consistent lesion creation, and widespread integration into thyroid ablation workflows across clinical settings.
- Thyroid Nodules are the fastest-growing application as clinicians increasingly adopt minimally invasive treatments for symptomatic or clinically relevant nodules, expanding procedural use beyond traditional surgical approaches.
Market Expansion Drivers
- Rising incidence of thyroid cancer and nodules increasing demand for minimally invasive ablation treatments.
- Integration of AI and robotic-assisted systems improving procedural precision and outcomes.
- Preference shift toward outpatient minimally invasive thyroid procedures reducing surgical burden.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Major companies in the thyroid ablation devices market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Olympus Corporation (Japan), Johnson & Johnson (United States), Integra LifeSciences Holdings Corporation (United States), Terumo Corporation (Japan), Theraclion SA (France), STARmed Co., Ltd. (South Korea), MedWaves, Inc. (United States), BVM Medical Limited (United Kingdom).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As the diagnosed pool of thyroid nodules and thyroid cancer cases expands, clinicians are encountering a larger group of patients who need treatment but do not always require or want conventional surgery. This is driving demand for the thyroid ablation devices market by increasing the use of thermal ablation approaches for benign nodules, recurrent disease, and carefully selected malignancies where preserving thyroid function, limiting scarring, and avoiding hospital-based surgery influence treatment decisions. In practice, higher case volumes push endocrinologists, interventional radiologists, and thyroid specialists to adopt device-based treatment pathways that can manage growing patient throughput with shorter procedures and less recovery time, reinforcing market demand for platforms, applicators, and imaging-guided ablation systems.
Integration of AI and robotic-assisted systems improving procedural precision and outcomes
The integration of AI and robotic-assisted technologies is strengthening market development in the thyroid ablation devices market by improving how precisely operators plan needle placement, define ablation zones, and protect critical neck structures during treatment. Thyroid interventions require careful navigation around nerves, vessels, and small target lesions, so tools that support real-time imaging interpretation, trajectory guidance, and more stable instrument control can reduce operator variability and expand physician confidence in offering ablation to a wider patient set. This practical improvement in procedural consistency supports adoption by hospitals and specialty centers that evaluate new systems based on outcomes, workflow reliability, and the ability to standardize treatment quality across different users.
Preference shift toward outpatient minimally invasive thyroid procedures reducing surgical burden
A clear move toward outpatient care is increasing market penetration for the thyroid ablation devices market because health systems and patients are placing greater value on procedures that avoid operating room time, general anesthesia, and extended recovery associated with thyroid surgery. In practice, minimally invasive ablation fits this shift by allowing providers to treat suitable thyroid lesions in ambulatory settings with lower resource intensity, which helps hospitals manage surgical backlogs and gives physicians a treatment option for patients seeking faster return to normal activity. That change in care delivery is supporting market expansion by directing procurement and clinical pathway decisions toward compact, image-guided ablation technologies designed for office-based and same-day treatment models.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising incidence of thyroid cancer and nodules increasing demand for minimally invasive ablation treatments | 2.30% | High | North America, Europe, Asia Pacific | High | Near Term |
| Integration of AI and robotic-assisted systems improving procedural precision and outcomes | 2.00% | High | North America, Europe | Medium | Mid Term |
| Preference shift toward outpatient minimally invasive thyroid procedures reducing surgical burden | 1.50% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 37.42% share of the thyroid ablation devices market in 2025, bolstered by established interventional treatment pathways, broad availability of image-guided procedures, and stronger integration of minimally invasive thyroid care across specialist settings. The region’s leadership is reinforced by the concentration of hospitals and outpatient centers equipped to perform ablation procedures, along with higher procedural familiarity among endocrinologists, radiologists, and thyroid surgeons. In practice, this supports steadier use of ablation as clinicians manage benign thyroid nodules with techniques that can reduce the need for conventional surgery and fit more efficiently into existing care workflows.
Asia Pacific is projected to expand at a 10.96% CAGR over the forecast period, with growth in the thyroid ablation devices market being impelled by widening access to advanced procedural care and rising adoption of minimally invasive thyroid interventions across major healthcare systems. Demand is accelerating as providers increase use of ultrasound-guided treatment approaches and as healthcare infrastructure in key countries becomes more capable of supporting specialized thyroid procedures. Practical uptake is also being encouraged by a larger treatment-seeking patient base and the growing preference for less invasive options that can shorten recovery time and reduce pressure on surgical capacity.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Treatment IntegrationGermany emphasizes clinically validated thyroid ablation devices supported by advanced imaging and standardized treatment protocols. German hospitals continue integrating minimally invasive solutions that improve procedural accuracy and patient outcomes.
France 🇫🇷
Clinical Practice ExpansionFrance is incorporating thyroid ablation devices into endocrine treatment pathways for carefully selected patients seeking non-surgical interventions. Hospitals increasingly emphasize physician training and consistent procedural standards to support broader clinical adoption.
Italy 🇮🇹
Outpatient Treatment GrowthItaly is expanding the use of thyroid ablation devices in outpatient settings where minimally invasive procedures can improve patient convenience. Healthcare facilities prioritize reliable technologies that support accurate treatment planning and streamlined recovery.
Japan 🇯🇵
Image-Guided Care FocusJapan is strengthening the use of thyroid ablation devices within specialized endocrine care, supported by demand for less invasive therapeutic options. Japanese clinicians prioritize precise image-guided interventions that preserve healthy thyroid tissue whenever appropriate.
South Korea 🇰🇷
Technology-Driven ProceduresSouth Korea continues advancing thyroid ablation device adoption through experienced specialists and strong utilization of ultrasound-guided therapies. Healthcare providers focus on expanding minimally invasive treatment options while improving procedural efficiency.
United States 🇺🇸
Minimally Invasive AdoptionThe U.S. thyroid ablation devices market is expanding through wider adoption of minimally invasive procedures for benign thyroid nodules. Healthcare providers increasingly invest in image-guided technologies that reduce recovery time while offering alternatives to conventional surgery.
Segment Leadership and Growth Trends
Thyroid Ablation Devices Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWithin the thyroid ablation devices market, Thermal Based Devices held the strongest position in 2025 with a 67.9% share. This leadership is underpinned by their established use across thyroid ablation procedures, where clinicians rely on proven procedural familiarity, consistent lesion creation, and broad integration into treatment workflows. Their continued dominance in the market reflects the practical advantage of technologies that are already well understood by operators and supported by existing procedural experience in thyroid-focused interventions.
Non-Thermal Based Devices are emerging as the fastest-growing segment in the thyroid ablation devices market as treatment preferences increasingly favor approaches that can address thyroid tissue while seeking greater procedural control in selected cases. Their momentum relative to thermal alternatives is being supported by growing interest in techniques that expand physician options beyond conventional heat-based ablation, especially where evolving clinical requirements call for more tailored intervention strategies. As the market matures, this widening acceptance is helping accelerate adoption of non-thermal platforms.
Application Segment Analysis: Thyroid Cancer (Largest Segment) vs Thyroid Nodules (Fastest-Growing Segment)
By application, Thyroid Cancer accounted for the largest position in the thyroid ablation devices market in 2025, holding a 64.99% share. its position is tied to the clear clinical need for intervention in malignant thyroid conditions, where ablation devices are used in response to cases that require targeted tissue destruction with procedural precision. This sustained share in the market is supported by the seriousness of the disease setting, which reinforces steady demand for device-based treatment approaches in thyroid cancer management.
Thyroid Nodules represent the fastest-growing application in the thyroid ablation devices market, influenced by rising use of minimally invasive treatment options for patients who need intervention but may not require more invasive conventional pathways. Growth is gaining pace because nodules present a broader practical treatment pool relative to cancer-specific cases, encouraging wider procedural adoption as physicians look for efficient ways to manage symptomatic or clinically relevant thyroid lesions. This expanding use case is giving the segment stronger momentum than alternative applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Thermal Based Devices, Non-Thermal Based Devices | Thermal Based Devices | Non-Thermal Based Devices |
| Application | Thyroid Cancer, Thyroid Nodules | Thyroid Cancer | Thyroid Nodules |
| End-use | Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Type | Radiofrequency Ablation, Microwave Ablation, Others | Radiofrequency Ablation | Microwave Ablation |
Competitive Landscape and Market Positioning
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. Olympus Corporation (Japan)
4. Johnson & Johnson (United States)
5. Integra LifeSciences Holdings Corporation (United States)
6. Terumo Corporation (Japan)
7. Theraclion SA (France)
8. STARmed Co. Ltd. (South Korea)
9. MedWaves Inc. (United States)
10. BVM Medical Limited (United Kingdom)
The thyroid ablation devices market is advancing through improvements in minimally invasive treatment technologies. Innovation focuses on enhancing precision targeting and procedural safety. The thyroid ablation devices market is also influenced by increasing demand for non-surgical treatment alternatives. Continuous device refinement is improving clinical efficiency and outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boston Scientific Corporation | Dec-22 | Boston Scientific acquired a majority stake in Acotec Scientific Holdings in December 2022. The acquisition expands its interventional portfolio, including access to radiofrequency ablation technologies and related minimally invasive therapeutic device capabilities. |
| Baird Medical | Jul-23 | Baird Medical received China NMPA Class III approval in July 2023 for its microwave ablation disposable needle used in thyroid nodule treatment. The clearance strengthens its regulatory position in energy-based thyroid ablation technologies and supports domestic commercialization. |
| STARmed Co., Ltd. | Aug-23 | STARmed established STARmed America in August 2023 to expand its direct presence in the U.S. market. The subsidiary enhances commercial reach and supports distribution and clinical collaboration for its thermal ablation technologies in North America. |
| Baird Medical | Mar-24 | Baird Medical obtained NMPA Class III approval for its radiofrequency ablation system in March 2024, marking regulatory clearance for thyroid indications. The approval strengthened competitive positioning in China and contributed to pricing pressure across imported ablation devices. |
| PIUR Imaging | Feb-24 | PIUR Imaging launched the tUS Infinity AI-enabled 3D ultrasound platform in February 2024. The system improves procedural efficiency in thyroid ablation workflows by enhancing imaging precision and reducing treatment time while supporting improved lesion volume reduction outcomes. |
| Hygea | Jan-24 | Hygea received U.S. FDA 510(k) clearance in January 2024 for its microwave ablation platform. The approval expands available energy-based treatment options for thyroid interventions and supports broader clinical adoption in minimally invasive ablation procedures. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Thyroid Ablation Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Thyroid Ablation Devices Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the thyroid ablation devices market?
How much is the thyroid ablation devices industry expected to grow by 2035?
How is the shift toward minimally invasive thyroid treatments affecting market adoption of ablation devices?
How are AI and robotic-assisted technologies improving procedural adoption in thyroid ablation procedures?
Why do Thermal Based Devices lead the thyroid ablation devices market?
Why are Thyroid Nodules the fastest-growing application in the thyroid ablation devices market?
Why is North America the leading region in the thyroid ablation devices market?
What is driving rapid growth in the thyroid ablation devices market across Asia Pacific?
Who are the leading players in the thyroid ablation devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization